Another Canadian Biotech get bought , not Zenith yet

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2647 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Another Canadian Biotech get bought , not Zenith yet

posted on Mar 19, 2024 12:34PM

Strange times that DM can't get a deal done yet, yet the small peer Biotech in the same space " metastatic castration-resistant prostate cancer" get bought for $2.4 Billion USD

Is it possible a deal will ever get done at a similar valuation....

https://ca.finance.yahoo.com/news/astrazeneca-buy-canadian-cancer-treatment-123229806.html

6 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply